Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs

Journal of Clinical Oncology

Volumn 27, Issue 2, 2009, Pages 250-255

  Leleu, Xavier ^a   Soumerai, Jacob ^a   Roccaro, Aldo ^a   Hatjiharissi, Evdoxia ^a   Hunter, Zachary R ^a   Manning, Robert ^a   Ciccarelli, Bryan T ^a   Sacco, Antonio ^a   Ioakimidis, Leukothea ^a   Adamia, Sophia ^a   Moreau, Anne Sophie ^a   Patterson, Christopher J ^a   Ghobrial, Irene M ^a   Treon, Steven P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CLADRIBINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUDARABINE; NUCLEOSIDE ANALOG; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE; CHLORAMBUCIL; DRUG DERIVATIVE; NUCLEOSIDE; VIDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER REGRESSION; FEMALE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; WALDENSTROEM MACROGLOBULINEMIA; CELL TRANSFORMATION; FOLLOW UP; INCIDENCE; MIDDLE AGED; NONHODGKIN LYMPHOMA; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; CHLORAMBUCIL; CLADRIBINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NUCLEOSIDES; RETROSPECTIVE STUDIES; VIDARABINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 58249093949     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.1530     Document Type: Article

References (20)

1. Treon SP, Gertz MA, Dimopoulos M, et al: Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia. Blood 107:3442-3446, 2006
2. Vijay A, Gertz MA: Waldenstrom Macroglobulinemia. Blood 109:5096-5103, 2007
3. Tsimberidou AM, Keating MJ: Richter syndrome: Biology, incidence, and therapeutic strategies. Cancer 103:216-228, 2005
4. Thornton PD, Bellas C, Santon A, et al: Richter's transformation of chronic lymphocytic leukemia: The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leuk Res 29:389-395, 2005
5. Hamada T, Ishizuka H, Asai Y, et al: A case of anaplastic large cell (Ki-1) lymphoma of B-cell phenotype, occurring in Waldenstrom's macroglobulinemia. Pathol Int 49:913-917, 1999
6. Lin P, Mansoor A, Bueso-Ramos C, et al: Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia: Clinicopathologic features of 12 cases. Am J Clin Pathol 120:246-253, 2003
7. Leblond V, Ben-Othman T, Deconinck E, et al: Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases - Groupe Cooperatif Macroglobulinemie. J Clin Oncol 16:2060-2064, 1998
8. Leblond V, Levy V, Maloisel F, et al: Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin- prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease. Blood 98:2640-2644, 2001
9. Tamburini J, Levy V, Chaleteix C, et al: Fludarabine plus cyclophosphamide in Waldenstrom's macroglobulinemia: Results in 49 patients. Leukemia 19:1831-1834, 2005
10. Ling S, Joshua DE, Gibson J, et al: Transformation and progression of Waldenstrom's macroglobulinemia following cladribine therapy in two cases: Natural evolution or iatrogenic causation? Am J Hematol 81:110-114, 2006
11. André M, Mounier N, Leleu X, et al: Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients. Blood 103:1222-1228, 2004
12. Morrison VA, Rai KR, Peterson BL, et al: Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 20:3878-3884, 2002
13. Delannoy A, Van Den Neste E, Michaux JL, et al: Cladribine for Waldenstrom's macroglobulinaemia. Br J Haematol 104:933-934, 1999
14. Owen RG, Treon SP, Al-Katib A, et al: Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30:110-115, 2003
15. SPSS/PC+: Statistical package for social science, user's guide. Chicago, IL, SPSS, 1986
16. Narayan H, Bandyopadhyay D, Schmidt K, et al: Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy. Clin Lab Haematol 27:405-408, 2005
17. Tsimberidou AM, O'Brien S, Khouri I, et al: Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol 24:2343-2351, 2006
18. Smith SM, Le Beau MM, Huo D, et al: Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: The University of Chicago series. Blood 102:43-52, 2003
19. Lam CC, Ma ES, Kwong YL: Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. Am J Hematol 79:288-290, 2005
20. Shin SJ, Chun SH, Kim KO, et al: Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenstrom's macroglobulinemia after sequential treatment with chlorambucil and fludarabine. Jpn J Clin Oncol 35:622-625, 2005